5140.0 From Local to National Perspectives: Substance Use in America

Wednesday, November 10, 2010: 12:30 PM - 2:00 PM
This session will look at various elements of substance abuse that are related to outcomes. Specifically correlates of marijuana use, effectiveness of buprenorphine treatment, and DEA drug scheduling as it relates to morbidity and mortality will be discussed.
Session Objectives: Describe marijuana use in African Americans Describe use of buprenorphine for opioid dependence Describe the relationships between DEA drug scheduling and morbidity/mortality
Richard W. Wilson, DHSc, MPH

Expanding Access to Treatment for Opioid Addiction: The Baltimore Buprenorphine Initiatve
Marla Oros, MS, RN, Vanessa T. Kuhn, MPH, Bonnie Campbell, LCSW and Sadie Smith, MSW
Relationship between drug morbidity and mortality and the DEA's scheduling of drugs
Victoria A. Albright, MA and Elizabeth H. Crane, PhD, MPH

See individual abstracts for presenting author's disclosure statement and author's information.

Organized by: Alcohol, Tobacco, and Other Drugs
Endorsed by: Community Health Planning and Policy Development, Epidemiology

CE Credits: Medical (CME), Health Education (CHES), Nursing (CNE), Public Health (CPH)